Viral Proteomics
Hepatitis C virus core protein impedes cell cycle progression
Published in Hepatitis Weekly, May 10th, 2004
According to researchers in Japan, "we investigated how the hepatitis C virus (HCV) core protein affects the cell cycle profile and cell cycle-related molecules by using the HCV core-expressing stable transfectant. Analysis of the cell cycle profile showed that HCV core impaired G1 to S transition. The E2F-mediated transcription, phosphorylation of the retinoblastoma protein, and cyclin-dependent kinase (CDK) 4 and CDK2 activities were suppressed in HCV core-expressing cells.
"The expression levels of G1 phase-related CDKs/cyclins and various CDK inhibitors were not substantially affected...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-05-10)
More Articles from Hepatitis Weekly
- Drug Development
Murine hepatitis models can screen for Cav 1.3-specific therapy - Liver Cancer Therapy
Vesicular stomatitis virus infusions staunch hepatocellular carcinoma in rats - Microbiology
Autoimmune liver disease patients show evidence of Helicobacter infection - Oncogenesis
Hepatitis B virus preS1 sequences stimulate squamous cell carcinoma antigen - Oncogenesis
Specific hepatitis B virus mutations predict liver cancer formation - Adverse Drug Effects
Interferon-alpha stimulates optic neuropathy in a chronic hepatitis C patient - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
